Capstone Development Solutions partners with the world’s premier healthcare companies to support their goal of bringing more new products to market, quickly and efficiently. The company leads development, manages regulatory services and achieves timely approval of pharmaceutical and medical device products on its clients' behalf. Water Street established Capstone in 2013 as a new way to support healthcare companies with expanding their product development portfolios without increasing their operating expenses. It is one of the few strategic investment firms to offer this unique solution. Dan Robins, PhD, who has more than 25 years of research and development experience, leads the company’s team of scientists and regulatory experts. Al Heller, former CEO of American Pharmaceutical Partners (APPI), serves as Capstone's chairman.